Willingness to accept COVID-19 vaccine among the elderly and the chronic disease population in China

Wang, Jiahao; Yuan, Beibei; Lu, Xinran; Liu, Xiaoxue; Li, Li; Geng, Shufan; Zhang, Haijun; Lai, Xiaozhen; Lyu, Yun; Feng, Haibo; Jing, Rize; Guo, Jia; Huang, Yingzhe; Liang, Xun; Wang, Yu; Fang, Hai

doi:10.1080/21645515.2021.2009290

Cited by 63 publications

(58 citation statements)

References 56 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The dynamic COVID-Zero strategy, successful until the emergence of the Omicron variant, might have resulted in further complacency, particularly among older persons. A survey conducted during November 2020–January 2021 in China found that older adults were more likely to accept a COVID-19 vaccine if they perceived themselves to be at high risk for infection or had trust in the government ( 10 ). Experience with the COVID-19 pandemic can motivate public health officials to increase vaccine distribution and coverage.…”

Section: Discussionmentioning

confidence: 99%

COVID-19 Mortality and Vaccine Coverage — Hong Kong Special Administrative Region, China, January 6, 2022–March 21, 2022

Smith¹,

Hakim²,

Leung³

et al. 2022

MMWR Morb. Mortal. Wkly. Rep.

109

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

COVID-19 Mortality and Vaccine Coverage — Hong Kong Special Administrative Region, China, January 6, 2022–March 21, 2022

Smith¹,

Hakim²,

Leung³

et al. 2022

MMWR Morb. Mortal. Wkly. Rep.

109

View full text Add to dashboard Cite

“…As the number of people suffering from diabetes continues to increase, it will bring a huge burden to China's health and economy. Despite studies indicating increased hesitation to SARS-CoV-2 immunization in chronic illness groups, diabetic individuals are an essential component and typical of the chronic disease community [15]. However, there are various kinds of chronic patients, and it is extremely difficult to recruit all these kinds of patients in one study.…”

Section: Introductionmentioning

confidence: 99%

COVID-19 Vaccine Hesitancy and Associated Factors among Diabetes Patients: A Cross-Sectional Survey in Changzhi, Shanxi, China

Wang

Duan

et al. 2022

Vaccines

View full text Add to dashboard Cite

Patients with diabetes are more susceptible to severe acute respiratory syndrome-associated coronavirus (SARS-CoV)-2 infection, but vaccine hesitancy is a problem in this population. We investigated the prevalence of SARS-CoV-2 vaccine hesitancy among diabetes patients in China through a cross-sectional survey from April and August 2021 using a questionnaire administered to patients at two hospitals affiliated with Changzhi Medical College (Shanxi, China). The health belief model (HBM) is used examining factors influencing vaccine hesitancy. After adjusting for potential confounders, a multivariate logistic regression model was used to analyze correlations between vaccine hesitancy and associated factors. Of the 483 participants, 56.4% (273/483) had vaccine hesitancy, including 58.2% (159/273) who were unsure of being vaccinated and 41.8% (114/273) who were unwilling. Although patients considered SARS-CoV-2 infection to be serious (adjusted odds ratio [aOR] = 3.90, 95% confidence interval [CI]: 2.36–6.42; p < 0.001), they had concerns about vaccine safety (aOR = 3.05, 95% CI: 1.89–4.91; p < 0.001). Relatives’ vaccination status did not influence participants’ willingness to be vaccinated (aOR = 2.43, 95% CI: 1.39–4.25; p < 0.001). Disagreement with physicians’ view that vaccination can reduce SARS-CoV-2 infection risk was independently correlated with vaccine hesitancy (aOR = 2.25, 95% CI: 1.28–3.95; p < 0.001). Diabetes patients in China need to be educated on SARS-CoV-2 vaccine safety and protective effects to increase the vaccination rate in this population.

show abstract

“…Worldwide, older adults had a high level of acceptance of COVID-19 vaccination. The prevalence of willingness to receive COVID-19 vaccination among older adults was 91.3% in the United States, 66–92.7% in Italy, 92% in Israel, 84.1% in Canada, 81.7% in Malaysia, 79.1% in mainland China, and 71% in Lebanon and Brazil [ 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 ]. The prevalence of taking up at least one dose of COVID-19 vaccination was high among older adults in most parts of the world, for example, 79.1% in the United States (April 2021) [ 21 ], 94% in the United Kingdom (May 2021) [ 22 ], 94% in Singapore (October 2021) [ 23 ], and 80% in mainland China (November 2021) [ 24 ].…”

Section: Introductionmentioning

confidence: 99%

“…It is also important to understand determinants of COVID-19 vaccination specific to older adults to develop health promotional campaigns to cater to their needs. To our knowledge, at least 12 studies have investigated factors associated with willingness to take up COVID-19 vaccination among older adults [ 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 ], while fewer studies have looked at factors influencing actual uptake in this group [ 10 , 22 ]. Facilitators identified by these studies included a history of seasonal influenza vaccination [ 18 , 19 , 20 ]; perceived higher risk and severer consequences of COVID-19 [ 10 , 11 , 12 , 14 , 17 , 19 , 20 ]; belief in vaccine efficacy and other benefits [ 10 , 13 , 14 , 15 , 17 ]; trust in vaccination information obtained from social media, friends, or family members [ 11 , 14 ]; higher social support [ 11 ]; and trust in the healthcare system, healthcare workers, or the government [ 11 , 14 ].…”

Section: Introductionmentioning

confidence: 99%

“…To our knowledge, at least 12 studies have investigated factors associated with willingness to take up COVID-19 vaccination among older adults [ 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 ], while fewer studies have looked at factors influencing actual uptake in this group [ 10 , 22 ]. Facilitators identified by these studies included a history of seasonal influenza vaccination [ 18 , 19 , 20 ]; perceived higher risk and severer consequences of COVID-19 [ 10 , 11 , 12 , 14 , 17 , 19 , 20 ]; belief in vaccine efficacy and other benefits [ 10 , 13 , 14 , 15 , 17 ]; trust in vaccination information obtained from social media, friends, or family members [ 11 , 14 ]; higher social support [ 11 ]; and trust in the healthcare system, healthcare workers, or the government [ 11 , 14 ]. Barriers to receive COVID-19 vaccination found by these studies included ethnicity (Hispanic, Black, or African American) [ 9 , 16 ], lower education or income [ 9 , 19 , 20 ], aged over 70 years [ 13 , 19 ], and concerns about safety and side-effects of the vaccines [ 10 , 15 , 16 , 19 ,…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Governmental Incentives, Satisfaction with Health Promotional Materials, and COVID-19 Vaccination Uptake among Community-Dwelling Older Adults in Hong Kong: A Random Telephone Survey

Wang

Fang

et al. 2022

Vaccines

View full text Add to dashboard Cite

COVID-19 vaccination is proven to be effective and safe for older adults. This study investigated the impacts of incentives and health promotional materials provided by the government on the completion of the primary COVID-19 vaccination series among older adults in Hong Kong. Participants were Chinese-speaking community-dwelling adults aged ≥65 years. Telephone numbers were randomly selected from up-to-date Hong Kong telephone directories. A total of 440 participants completed the telephone interview. Logistic regression models were fitted. Among the participants, 58.4% had completed the primary COVID-19 vaccination series. Most participants believed that incentives provided by the government had almost no impact on increasing their motivation to receive COVID-19 vaccination, and less than half thought that vaccination promotional materials produced by the government could address their concerns and help them make decisions. After adjustment for significant background characteristics, we found perceived higher impacts of the incentives and belief that vaccination promotional materials produced by the government could address their concern and were helpful for them to make decisions to be associated with a higher rate of completion of primary COVID-19 vaccination series. Perceptions supporting COVID-19 vaccination and less decisional conflict regarding the choice of vaccine were also positively associated with the dependent variable. Government should develop incentives and health promotional materials tailored to the needs of older adults.

show abstract

Willingness to accept COVID-19 vaccine among the elderly and the chronic disease population in China

Cited by 63 publications

References 56 publications

COVID-19 Mortality and Vaccine Coverage — Hong Kong Special Administrative Region, China, January 6, 2022–March 21, 2022

COVID-19 Mortality and Vaccine Coverage — Hong Kong Special Administrative Region, China, January 6, 2022–March 21, 2022

COVID-19 Vaccine Hesitancy and Associated Factors among Diabetes Patients: A Cross-Sectional Survey in Changzhi, Shanxi, China

Governmental Incentives, Satisfaction with Health Promotional Materials, and COVID-19 Vaccination Uptake among Community-Dwelling Older Adults in Hong Kong: A Random Telephone Survey

Contact Info

Product

Resources

About